Hackensack Participated in Nationwide Study that Finds Three Medications are Safe and Effective in Treating LifeThreatening Seizures
What you need to know
Hackensack University Medical Center researchers in Emergency Medicine participated in a nationwide study published in the New England Journal of Medicine in November 2019 that concluded that three drugs are equally safe and effective in treating patients with life-threatening seizures called Status Epilepticus (SE). The new study, Established Status Epilepticus Treatment Trial (ESETT), examined three medications commonly administered in the emergency department to treat SE – levetiracetam, fosphenytoin, and valproate – in order to learn which is most effective in treating patients. There are approximately 120,000 to 180,000 episodes of SE in the United States each year.
More details about the study
Hackensack University Medical Center was one of 58 sites in the nation to participate in this groundbreaking study. The Philadelphia Neurological Emergencies Treatment Trials, or Phila-NETT, a National Institute of Neurological Disorders and Stroke (NINDS) sponsored network of hub and spoke hospitals conducting emergency neurological research, supported by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH).
